Chemical industry – Page 76
-
BusinessPrice caps provoke lawsuits from Indian pharma industry
New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups
-
Business
Tetraethyl lead bribery case ends with four executives convicted
Three jailed over corruption to prolong sales of fuel additives in Iraq and Indonesia
-
Business
Amgen to shed 2400-2900 jobs
Restructuring will see three sites close as company comes under pressure to streamline R&D, despite successes
-
Business
AstraZeneca stocks respiratory and cancer pipelines
A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company
-
Business
Bruker winds down underperforming instrument lines
Stand-alone gas chromatographs and certain mass spectrometry products to be sold off
-
Business
Reckitt Benckiser to spin out US pharma arm
Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products
-
BusinessTakeover battle pushes Allergan to cut R&D jobs
Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth
-
BusinessPharma firms rush to escape US tax shackles
AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries
-
Business
Tata Chemicals to mothball Kenya plant
Closure blamed on high energy prices and will mean 200 jobs being cut
-
BusinessInvestigators find cause of West Virginia chemical spill
Holes in uninspected storage tanks led to leak that contaminated water supplies
-
Business
Albemarle buys into lithium with Rockwood merger
$6.2 billion deal capitalises on battery market growth
-
Business
Co-operation keeps contracts coming
Clubbing together gives contract research organisations more power to win new business in an evolving market
-
Business
China struggles to speed up drug reviews
Regulator considers outsourcing reviews, and creates a fast-track scheme for priority generics
-
Business
First of a new breed of anticancer antibodies approved in Japan
Ono claims Opdivo is the first anti-PD1 treatment in the world
-
Business
ADM to buy food ingredients specialist Wild Flavors
€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
Ineos takes full control of Styrolution
€1.1bn deal sees BASF complete its planned exit from styrenics joint venture
-
Business
Genentech to buy breast cancer specialist Seragon
$1.7bn deal for hormone receptor-destroying drug pipeline
-
Business
PPG to buy Mexican paints firm Comex
$2.3bn deal expands US firm’s footprint in Central America
-
Business
Bayer to close polycarbonate plant and cut 90 jobs
Firm has already shut Chinese plant, and will also sell off businesses in Australia and New Zealand